At month 3 , BBFC lowered mean diurnal IOP from baseline to a significantly greater extent than brinzolamide ( least squares [ LS ] mean difference : -1.4 mmHg ; P < 0.0001 ; t test ) and brimonidine ( LS mean difference : -1.5 mmHg ; P < 0.0001 ) .